Constar International Inc. Announces First Quarter 2006 Results
15 Mai 2006 - 12:00PM
Business Wire
Constar International Inc. (NASDAQ: CNST) today announced its
financial results for the first quarter of 2006. Highlights when
compared to the first quarter of 2005 include: -- Net sales of
$230.7 million up 4.3 percent. -- Custom unit sales increased 40.5
percent. -- Gross profit percentage improved to 5.5 percent from
2.9 percent. -- Operating income of $3.6 million improved versus a
loss of $11.3 million. -- Credit Agreement EBITDA of $12.1 million,
up 7.6 percent. -- Net loss reduced by $13.7 million to $6.3
million. "In the quarter we grew custom unit sales by 40.5%,
further improved US operating performance, and significantly abated
price erosion through our strategic pricing initiative," said
Michael Hoffman, CEO and President of Constar. He added, "Improved
results were accomplished despite higher energy costs net of
customer surcharges, and despite higher administrative costs
incurred during the quarter to enhance internal controls. We are
pleased with our financial performance in the quarter." Net sales
increased 4.3 percent in the first quarter of 2006 to $230.7
million compared to $221.3 million in the first quarter of 2005.
This increase primarily reflects increased shipments of custom
products, partially offset by unfavorable foreign currency
translation. Gross profit in the first quarter of 2006 of $12.8
million increased to 5.5 percent of net sales from 2.9 percent in
the first quarter of 2005. Depreciation of $8.2 million was $3.1
million lower in the quarter compared to the first quarter of 2005
principally because of a lower asset base, partially related to a
2005 third quarter non-cash asset impairment charge. Net of
depreciation, gross profit in the first quarter of 2006 was up $3.3
million compared to the first quarter of 2005. The increase was
primarily due to higher unit sales, improved product mix and better
operating efficiencies in the U.S. business, partially offset by
higher utility costs. Selling and administrative and research and
technology expenses of $8.9 million increased $1.3 million in the
first quarter of 2006 from $7.6 million in the first quarter of
2005. The increase was primarily the result of a $0.9 million
increase in audit costs, higher legal fees and higher compensation
expenses in the first quarter of 2006. Interest expense in the
first quarter of 2006 of $10.2 million increased 5.6 percent,
compared to $9.6 million in the prior year period as a result of
higher average borrowings and a higher effective interest rate.
Operating income of $3.6 million for the first quarter of 2006
improved from the first quarter of 2005 operating loss of $11.3
million because of the enhanced operating performance outlined
above and the absence in 2006 of the $10.0 million write off of
deferred financing costs recorded in the first quarter of 2005. The
Company reported a net loss in the first quarter of $6.3 million,
or $0.52 loss per basic and diluted share, compared to a net loss
of $20.0, million or $1.65 loss per basic and diluted share in the
first quarter of 2005. The net loss was lower in the first quarter
of 2006 primarily because of the same factors which lead to the
improvement in operating income described above. Credit Agreement
EBITDA in the first quarter increased by 7.6 percent to $12.1
million from $11.3 million in the first quarter of 2005. This
increase was primarily due to higher gross profit excluding
depreciation expense, partially offset by increased operating
expenses. EBITDA is defined by the Company as net income (loss)
before interest expense, provision for income taxes, depreciation
and amortization. The Company's Credit Agreement adjusts EBITDA for
certain items. In the first quarter of 2006, these adjustments
amounted to less than $0.1 million. In the first quarter of 2005,
these adjustments were $10.9 million, which included the write off
of deferred financing costs of $10.0 million. Credit Agreement
EBITDA is not a GAAP-defined measure and may not be comparable to
adjusted EBITDA as defined by other companies. Management believes
that investors, analysts and other interested parties view our
ability to generate Credit Agreement EBITDA as an important
indicator of our operating performance. Management also believes
that Credit Agreement EBITDA is a useful measure in understanding
trends because it eliminates various non-operational and
non-recurring items. In addition, Credit Agreement EBITDA
facilitates comparisons to operating performance in prior periods,
and is used by the Company in setting incentive plan targets.
Investors are urged to take into account GAAP measures in
evaluating the Company, and to review the reconciliation of Credit
Agreement EBITDA to net income (loss) in the attached unaudited
consolidated statements of operations. Conference Call, Web Cast
Information The Company will hold a conference call on Monday May
15, 2006, at 9:00 a.m. ET to discuss this news release.
Forward-looking and other material information will be discussed on
this conference call. The dial-in numbers for the conference call
are (800) 810-0924 (domestic callers) or (913) 981-4900
(international callers). The conference call will also be broadcast
live over the internet and can be accessed via the Company's
website: www.constar.net. Please log on approximately 15 minutes
prior to the call to register and download any necessary audio
software. A replay of the broadcast will be available from 1:00
p.m. ET that day until midnight on Monday, May 22, 2006 and can be
accessed via telephone by dialing (888) 203-1112 (domestic callers)
or (719) 457-0820 (international callers) and entering passcode
5437569, or via the web at www.constar.net where it will be
archived. Cautionary Note Regarding Forward-Looking Statements
Except for historical information, all information in this news
release consists of forward-looking statements within the meaning
of the federal securities laws. These forward-looking statements
involve a number of risks, uncertainties and other factors, which
may cause the actual results to be materially different from those
expressed or implied in the forward-looking statements. Important
factors that could cause the statements made in this news release
or the actual results of operations or financial condition of the
Company to differ include the success of the Company's strategic
pricing initiative, the Company's ability to expand sales of custom
products and to improve the operating performance of its European
business. Other important factors are discussed under the caption
"Risk Factors" in the Company's Form 10-K Annual Report for the
year ended December 31, 2005 and in subsequent filings with the
Securities and Exchange Commission made prior to, on or after the
date hereof. The Company does not intend to review or revise any
particular forward-looking statement in light of future events.
About Constar Philadelphia-based Constar is a leading global
producer of PET (polyethylene terephthalate) plastic containers for
food, soft drinks and water. The Company provides full-service
packaging solutions, from product design and engineering, to
ongoing customer support. Its customers include many of the world's
leading branded consumer products companies. -0- *T CONSTAR
INTERNATIONAL INC. CONSOLIDATED STATEMENTS OF OPERATIONS COMPARISON
(in thousands, except per share data) (Unaudited) Three Months
Ended March 31, ------------------------ 2006 2005 ----------
---------- Net customer sales $ 229,735 $ 220,245 Net sales to
affiliates 957 1,034 ---------- ---------- Net sales 230,692
221,279 ---------- ---------- Cost of products sold, excluding
depreciation 209,727 203,607 Depreciation 8,183 11,301 ----------
---------- Gross profit 12,782 6,371 ---------- ---------- Selling
and administrative expense 7,589 6,144 Research and technology
expense 1,338 1,474 Write off deferred financing costs and other
fees - 10,025 Provision for restructuring 210 59 ----------
---------- Total operating expenses 9,137 17,702 ----------
---------- Operating income (loss) 3,645 (11,331) Interest expense
10,186 9,645 Other income, net (311) (415) ---------- ----------
Loss before taxes and minority interest (6,230) (20,561)
(Provision) benefit for income taxes (94) 522 Minority interests
(19) (9) ---------- ---------- Net loss $ (6,343) $ (20,048)
========== ========== Per common share data: Basic and diluted Net
loss $ (0.52) $ (1.65) Weighted average common shares outstanding:
Basic and diluted shares 12,197 12,119 Reconciliation of net income
(loss) to Credit Agreement EBITDA: Net loss $ (6,343) $ (20,048)
Add back: Interest expense 10,186 9,645 Taxes 94 (522) Depreciation
8,183 11,301 ---------- ---------- EBITDA 12,120 376 Other
adjustments under Credit Agreement 14 10,898 ---------- ----------
Credit Agreement EBITDA $ 12,134 $ 11,274 ========== ==========
--------------------------- SELECTED BALANCE SHEET DATA
--------------------------- March 31, 2006 -------------- Cash and
cash equivalents $ 7,922 Debt: Revolver Loan $ 25,588 Senior Notes
$ 220,000 Senior Subordinated Notes $ 175,000 *T
Constellation Pharmaceut... (NASDAQ:CNST)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Constellation Pharmaceut... (NASDAQ:CNST)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024